CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-31 | WECHSLER AMY B Director | Grant or award | +1,065 | $29.92 | $32K | 88,874 |
| 2019-12-31 | ROBERTSON RUSSEL C Director | Grant or award | +1,253 | $29.92 | $37K | 93,983 |
| 2019-12-31 | Paulson John Director | Grant or award | +919 | $29.92 | $27K | 55,712 |
| 2019-12-31 | DE SCHUTTER RICHARD U Director | Grant or award | +1,044 | $29.92 | $31K | 274,250 |
| 2019-12-16 | APPIO THOMAS Pres&Co-Head Bausch&Lomb/Int'l | Shares withheld for taxes | −3,337 | $31.00 | $103K | 159,344 |
| 2019-09-30 | WECHSLER AMY B Director | Grant or award | +1,458 | $21.85 | $32K | 87,809 |
| 2019-09-30 | ROBERTSON RUSSEL C Director | Grant or award | +1,716 | $21.85 | $37K | 92,730 |
| 2019-09-30 | Paulson John Director | Grant or award | +1,258 | $21.85 | $27K | 54,793 |
| 2019-09-30 | DE SCHUTTER RICHARD U Director | Grant or award | +1,430 | $21.85 | $31K | 273,206 |
| 2019-09-16 | PAPA JOSEPH C CHAIRMAN & CEO | Shares withheld for taxes | −5,115 | $23.24 | $119K | 855,734 |
| 2019-09-16 | Herendeen Paul EVP and CFO | Shares withheld for taxes | −1,642 | $23.24 | $38K | 253,718 |
| 2019-09-13 | PAPA JOSEPH C CHAIRMAN & CEO | Purchase | +30,000 | $23.31 | $699K | 839,601 |
| 2019-09-13 | PAPA JOSEPH C CHAIRMAN & CEO | Grant or award | +21,248 | 860,849 | ||
| 2019-08-23 | Herendeen Paul EVP and CFO | Shares withheld for taxes | −24,625 | $22.40 | $552K | 255,360 |
| 2019-08-19 | APPIO THOMAS Pres&Co-Head Bausch&Lomb/Int'l | Shares withheld for taxes | −8,362 | $21.30 | $178K | 162,681 |
| 2019-08-19 | McKenna Mark C. President, Salix | Sale | −10,773 | $21.83 | $235K | 20,756 |
| 2019-08-16 | Humphries William D. President, Ortho-Dermatologics | Purchase | +30,703 | $21.18 | $650K | 147,721 |
| 2019-08-16 | Humphries William D. President, Ortho-Dermatologics | Grant or award | +30,703 | 178,424 | ||
| 2019-08-12 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Sale | −3,418 | $22.45 | $77K | 50,525 |
| 2019-08-09 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Shares withheld for taxes | −7,779 | $22.39 | $174K | 53,943 |
Page 30 of 31 · 608 trades